engleski

Re: J. Alfred Witjes, Thierry Lebret, Eva M. Compérat, et al. Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Eur Urol 2017 ; 71:462-75.

We have been following with great interest the evolution of the European Association of Urology (EAU) guidelines for the treatment of muscle-invasive carcinoma of the urinary bladder. Since our department performs more than 100 cystectomies per year, of which> 50% involve orthotopic neobladders, we find the indications and contraindications for orthotopic urinary diversion of particular interest. The 2015 EAU guidelines made an important step forwards. They point to the fact that an orthotopic neobladder could be considered in patients with N1 involvement but not in those with N2 or N3 involvement. The recently published 2016 guidelines (Section 10.4 Diversion) state that an orthotopic neobladder can also be considered in patients with positive lymph nodes [1]. Obviously, the limits have shifted, so N2 and N3 tumours are no longer contraindications for orthotopic

Bladder carcinoma, surgery, guidelines

nije evidentirano